GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain

Ulrike Leurs(University of Copenhagen), Petrine Wellendorph(University of Copenhagen), Bente Frølund(University of Copenhagen), Line B. Palmelund(University of Copenhagen), Emma K. Gowing(Brain Research New Zealand), Robert O. Burnie(Brain Research New Zealand), Louise Hamborg(University of Copenhagen), Anders B. Klein(Copenhagen University Hospital), Birgitte Rahbek Kornum(University of Copenhagen), Stine B. Vogensen(University of Copenhagen), Ethan D. McSpadden(QB3), Anne Sofie G. Larsen(University of Copenhagen), John Kuriyan(Vanderbilt University), Sara M. Ø. Solbak(University of Copenhagen), Jesper V. Olsen(University of Copenhagen), Christine L. Gee(QB3), Christian D. Kelstrup(University of Copenhagen), Anders Bach(University of Copenhagen), Geeske M. van Woerden(NeuroDevelopment Center), Selina M. W. Teurlings(Erasmus MC), Douglas S. Kerr(University of Otago), Mohamed A. Shehata(University of Copenhagen), Inge S. Villumsen(University of Copenhagen), Rasmus P. Clausen(University of Copenhagen), Nane Griem‐Krey(University of Copenhagen), Chris Chi(QB3), Stine Juul Gauger(University of Copenhagen), Josh Houlton(Brain Research New Zealand), Andrew N. Clarkson(Brain Research New Zealand)
Proceedings of the National Academy of Sciences
July 30, 2021
Cited by 53


Related Papers